| Product Code: ETC7544449 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India glucocorticoid agonist market import shipment demonstrated a steady growth trend during the period of CAGR 2020-2024 at 4.7%. However, there was a slight slowdown in growth between 2023 and 2024, with a growth rate of 1.5%. Overall, the market expanded consistently, showing positive momentum.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Glucocorticoid Agonist Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Glucocorticoid Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 India Glucocorticoid Agonist Market - Industry Life Cycle |
3.4 India Glucocorticoid Agonist Market - Porter's Five Forces |
3.5 India Glucocorticoid Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 India Glucocorticoid Agonist Market Revenues & Volume Share, By Products, 2021 & 2031F |
3.7 India Glucocorticoid Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Glucocorticoid Agonist Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 India Glucocorticoid Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Glucocorticoid Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of inflammatory and autoimmune diseases in India |
4.2.2 Growing awareness about the benefits of glucocorticoid agonists in managing various medical conditions |
4.2.3 Rising healthcare expenditure and improving access to healthcare services in India |
4.3 Market Restraints |
4.3.1 Concerns regarding the side effects associated with long-term use of glucocorticoid agonists |
4.3.2 Stringent regulatory requirements for the approval and marketing of glucocorticoid agonists in India |
5 India Glucocorticoid Agonist Market Trends |
6 India Glucocorticoid Agonist Market, By Types |
6.1 India Glucocorticoid Agonist Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 India Glucocorticoid Agonist Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 India Glucocorticoid Agonist Market Revenues & Volume, By Anti-inflammatory, 2021- 2031F |
6.1.4 India Glucocorticoid Agonist Market Revenues & Volume, By Eyes Disorders, 2021- 2031F |
6.1.5 India Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Glucocorticoid Agonist Market, By Products |
6.2.1 Overview and Analysis |
6.2.2 India Glucocorticoid Agonist Market Revenues & Volume, By Corticosterone, 2021- 2031F |
6.2.3 India Glucocorticoid Agonist Market Revenues & Volume, By Fluticasone Propionate, 2021- 2031F |
6.2.4 India Glucocorticoid Agonist Market Revenues & Volume, By Methylprednisolone, 2021- 2031F |
6.2.5 India Glucocorticoid Agonist Market Revenues & Volume, By Mometasone Furoate, 2021- 2031F |
6.2.6 India Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Glucocorticoid Agonist Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Glucocorticoid Agonist Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 India Glucocorticoid Agonist Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 India Glucocorticoid Agonist Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.5 India Glucocorticoid Agonist Market Revenues & Volume, By Ocular, 2021- 2031F |
6.3.6 India Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Glucocorticoid Agonist Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 India Glucocorticoid Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 India Glucocorticoid Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 India Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Glucocorticoid Agonist Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Glucocorticoid Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 India Glucocorticoid Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 India Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
7 India Glucocorticoid Agonist Market Import-Export Trade Statistics |
7.1 India Glucocorticoid Agonist Market Export to Major Countries |
7.2 India Glucocorticoid Agonist Market Imports from Major Countries |
8 India Glucocorticoid Agonist Market Key Performance Indicators |
8.1 Patient adherence rate to glucocorticoid agonist treatment |
8.2 Number of new product launches or approvals in the glucocorticoid agonist market |
8.3 Rate of adoption of glucocorticoid agonists in different therapeutic areas |
9 India Glucocorticoid Agonist Market - Opportunity Assessment |
9.1 India Glucocorticoid Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 India Glucocorticoid Agonist Market Opportunity Assessment, By Products, 2021 & 2031F |
9.3 India Glucocorticoid Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Glucocorticoid Agonist Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 India Glucocorticoid Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Glucocorticoid Agonist Market - Competitive Landscape |
10.1 India Glucocorticoid Agonist Market Revenue Share, By Companies, 2024 |
10.2 India Glucocorticoid Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here